Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Menendez

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Biology|January 24, 2007
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1Daniel Menendez, Alberto Inga, Joyce Snipe, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2008
Functional evolution of the p53 regulatory network through its target response elementsAnil G Jegga, Alberto Inga, Daniel Menendez, et al.
Plos Genetics|April 13, 2011
The Toll-like receptor gene family is integrated into human DNA damage and p53 networksDaniel Menendez, Maria Shatz, Kathleen Azzam, et al.
Plos One|April 28, 2010
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compoundYari Ciribilli, Virginia Andreotti, Daniel Menendez, et al.
Cancer Research|August 17, 2012
RAP80 is critical in maintaining genomic stability and suppressing tumor developmentZhengyu Yin, Daniel Menendez, Michael A Resnick, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Low-level p53 expression changes transactivation rules and reveals superactivating sequencesJennifer J Jordan, Daniel Menendez, Jenia Sharav, et al.
Cell Cycle (Georgetown, Tex.)|March 23, 2013
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeuticsMattia Lion, Alessandra Bisio, Toma Tebaldi, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Nucleic Acids Research|June 19, 2013
Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cellsDaniel Menendez, Thuy-Ai Nguyen, Johannes M Freudenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2005
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivationDaniel J Tomso, Alberto Inga, Daniel Menendez, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Biology|January 24, 2007
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1Daniel Menendez, Alberto Inga, Joyce Snipe, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2008
Functional evolution of the p53 regulatory network through its target response elementsAnil G Jegga, Alberto Inga, Daniel Menendez, et al.
Plos Genetics|April 13, 2011
The Toll-like receptor gene family is integrated into human DNA damage and p53 networksDaniel Menendez, Maria Shatz, Kathleen Azzam, et al.
Plos One|April 28, 2010
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compoundYari Ciribilli, Virginia Andreotti, Daniel Menendez, et al.
Cancer Research|August 17, 2012
RAP80 is critical in maintaining genomic stability and suppressing tumor developmentZhengyu Yin, Daniel Menendez, Michael A Resnick, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Low-level p53 expression changes transactivation rules and reveals superactivating sequencesJennifer J Jordan, Daniel Menendez, Jenia Sharav, et al.
Cell Cycle (Georgetown, Tex.)|March 23, 2013
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeuticsMattia Lion, Alessandra Bisio, Toma Tebaldi, et al.
Plos Genetics|August 21, 2008
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53Jennifer J Jordan, Daniel Menendez, Alberto Inga, et al.
Nucleic Acids Research|June 19, 2013
Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cellsDaniel Menendez, Thuy-Ai Nguyen, Johannes M Freudenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2005
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivationDaniel J Tomso, Alberto Inga, Daniel Menendez, et al.
Pageof 5